AAV Vector Manufacturing Advances Hold the Key to Accessible Gene Therapy
Adeno-associated virus (AAV) vectors have become the delivery vehicle of choice for modern gene therapy, carrying therapeutic genes into cells ...
Adeno-associated virus (AAV) vectors have become the delivery vehicle of choice for modern gene therapy, carrying therapeutic genes into cells ...
The next revolution in cancer medicine may not come from a new drug molecule but from a family of proteins ...
A nationwide Swedish cohort study of 4,210 people with HIV shows that viral blips occur in about one in five ...
Immune checkpoint inhibitors have transformed the outlook for many patients with advanced cancer, but the same immune reawakening that lets ...
Graves’ disease is the most common cause of hyperthyroidism worldwide, and in roughly a quarter to half of patients it ...
A new review argues that B7-H3 positivity measured by immunohistochemistry is necessary but not sufficient to predict response to antibody-drug ...
The systematic review by Mahmoudi and colleagues arrives at a moment when the field of CAR T-cell therapy is confronting ...
For decades, patients with serious infections faced a stark choice: weeks confined to a hospital bed hooked to an intravenous ...
For decades, an unwritten rule has shaped cancer care: the older the patient, the gentler the treatment. Now a landmark ...
New research highlights microRNAs, mitochondrial ribosomal proteins and lactate signaling as promising targets against cancer's metabolic reprogramming.
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine